Machine learning algorithm predicted, in hindsight, which patients with melanoma would respond to treatment and which would not respond
Researchers “from [MORE]
Esophageal sponge collects genetic material for diagnosis
In order to retrieve biomarkers for cancer of the esophagus, a doctor at The [MORE]
Video Vitals
In regions where epidemic diseases rage, being able to determine vital signs, using a smartphone camera, is a decided [MORE]
John Hopkinds Cancer Test for 8 Cancers
Johns Hopkins researchers took blood samples from 1,005 patients with various cancers, and with [MORE]
Conceptual Model for SPADE
What percent of primary care physicians’ diagnoses are wrong? According to the Mayo Clinic, the figure is [MORE]
Schematic of an OTFT Device
Organic thin film transistors are dramatically changing the design and development of medical devices, and [MORE]
“Never events,” like leaving a sponge in a patient’s body, or wrong site-wrong procedure-wrong patient, are never supposed to [MORE]
SOX2, OCT4, KLF4, and MYC—the so called Yamanaka factors—that can transform somatic cells into induced pluripotent stem cells. In [MORE]
Johns Hopkins HealthCare Solutions (“Solutions”) is a recently created division of JHHC. Solutions is structured to commercialize innovative knowledge-based products and [MORE]
It will be a while before a technique Johns Hopkins bioengineers have developed for cartilage repair reaches clinical medicine, [MORE]
Finding a cure for Huntington’s disease has been limited to trials with living patients until now. Researchers at Johns [MORE]
Microfluidic Chemostat
Researchers in the Microfluidics Laboratory at Johns Hopkins have devised a lab chip that flows a blood sample [MORE]
Dr. Yoon-Young Jang
Yoon-Young Jang, MD and colleagues at the Johns Hopkins Kimmel Cancer Center recently reported that induced pluripotent [MORE]
William Busse
In this NIH listing of grant winners in 2009, Johns Hopkins University ranked first with nearly three-quarters of [MORE]